coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Gravesend Central PCN, Gravesham · Health Inequalities Profile

    PCN U27026 · NHS Kent and Medway Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    37,775

    Registered population

    63.9% aged 18–64

    13.4%

    Aged 65+

    ICB 19.9% · England 17.9%

    27.6%

    Ethnic minority (non-White)

    13.1% Asian · England 9.6%

    32.6%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~10,710

    Core20 residents (est.)

    Resident basis; registered basis ~11,521 · see page 3

    5,022

    Hypertension register

    +1.56% in 3 yrs · England +5.60%

    346

    SMI register

    37.5% of Gravesham's

    500

    COPD register

    Reviews +10.76% in 3 yrs

    Forecast to 2030

    6,076

    Hypertension patients, 2030

    +1,054 on today

    85.0%

    QRISK ≥20% on statins, 2030

    +9.32pp over 3 yrs

    2.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    53.9%
    Asthma annual reviews trail comparators and declined.

    Annual asthma reviews fell 5.4% over 2023 to 2025 to 53.9% (England 65.7%), leaving about 720 of 1,565 registered patients without a review.

    59.2%
    Working-age hypertension and diabetes control lag England.

    Blood pressure control under age 80 is 59.2% (England 67.8%, vs 79.1% aged 80+), while non-frail diabetes HbA1c control is 47.3% (England 57.4%).

    +18.0%
    Rapid three-year growth in lipid-lowering therapy.

    Patients with QRISK ≥ 20% on lipid-lowering therapy rose +18.0% over 2023 to 2025 to 61.8% (England +6.2%), at £1.30 per item (England £1.86).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger list and 27.6% ethnic diversity may shape local primary care demand

    Gravesend Central PCN has 37,775 registered patients, though practice lists sum to 35,752. The list is younger than benchmarks: 22.6% are aged 0-17 (Gravesham 22.1%, NHS Kent and Medway ICB 20.7%, England 19.6%) and 13.4% are aged 65+ (Gravesham 16.2%, ICB 19.9%, England 17.9%). Projected growth to 2030 is 7.2% (Gravesham 4.1%, ICB 6.0%, England 2.3%), under unverified methodology.

    Age profile

    0–1722.6%
    18–6463.9%
    65+13.4%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White72.4%
    Asian13.1%
    Black7.9%
    Other3.6%
    Mixed2.9%

    Older people · falls rows are Gravesham local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Gravesham LA)2,0112,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)78.8%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)47.3%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Gravesham LA)1,0559819552024/25
    Falls deaths, all ages, per 100,000 (Gravesham LA)13.114.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 32.6% PCN-wide, peaking at 38.3% at Gravesend Medical Centre

    Gravesend Central PCN has an average IMD decile of 3.6 (England 5.5). Registered Core20 patients reach 32.6%, above Gravesham (25.0%), NHS Kent and Medway ICB (17.1%) and England (21.0%). The weighted practice share is 32.2%, differing by 0.43 percentage points from the PCN figure. Practice share spans 14.3 pp: Gravesend Medical Centre is at 38.3% (6,393 estimated patients), Pelham Medical Practice at 27.6% (4,227 estimated patients), and Rochester Road Surgery at 24.0% (901 estimated patients).

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Gravesend38.3% · 6,393 patients
    Pelham Medical27.6% · 4,227 patients
    Rochester Road24.0% · 901 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    346

    SMI register

    0.97% recorded prevalence

    254

    Learning disability register

    0.71% recorded prevalence

    15

    Care homes, 591 beds

    In the PCN catchment

    9.3%

    Provide unpaid care

    Gravesham, Census 2021

    The PCN records 346 patients on the severe mental illness register (1.0%, England 1.0%) and 254 with learning disabilities (0.7%, England 0.6%). There are 15 care homes with 591 beds in the PCN catchment, which do not establish patient residence. For Gravesham, the autumn 2025 snapshot recorded 8 rough sleepers, and Census modelling yields an unpaid carer ceiling estimate of 3,513.

    Severe mental illness: physical health checks

    On the 346-patient SMI register, blood pressure checks reached 75.9% (England 83.4%) and BMI recording was 79.3% (England 82.1%), while alcohol recording for psychosis was 73.5% (England 81.8%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,022

    Hypertension register

    +1.56%

    Register growth, 3 yrs

    Gravesham +4.52% · England +5.60%

    +3.41pp

    BP control, under 80

    ≤140/90 · +7.06pp aged 80+

    +1,054

    More patients by 2030

    Forecast 6,076 (14.49%)

    Hypertension case-finding and control

    The hypertension register records 5,022 patients (14.1% prevalence), matching Gravesham (14.1%) but below NHS Kent and Medway ICB (16.2%) and England (15.2%). While blood pressure control aged 80+ reaches 79.1% (England 81.2%), control under age 80 is 59.2%, trailing Gravesham (62.9%), the ICB (64.6%) and England (67.8%), dropping to 46.6% at Rochester Road Surgery. Recent blood pressure recording is 83.1% (England 90.0%). Observation periods were not supplied, and the register implies a 35,693 base rather than the 37,775 list. Working-age blood pressure control lags national benchmarks across the PCN, with Rochester Road Surgery recording the lowest control rate.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy rose +18.0% over 2023 to 2025 to 61.8%, above Gravesham (58.9%) and NHS Kent and Medway ICB (61.4%) but below England (63.6%).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202659,920£1.30£1.90£1.86£77,896
    Cardiovascular (all), 202586,680£3.27£3.57£3.33£283,444

    In 2026, the PCN prescribed 59,920 lipid-regulating items at £1.30 per item, below Gravesham (£1.61), England (£1.86) and NHS Kent and Medway ICB (£1.90), spending £33,555 less than at England's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −5.38%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.09%

    Asthma prevalence, PCN 3-yr % change

    Asthma annual reviews fell 5.4% over 2023 to 2025 (England +4.4%) to 53.9% (England 65.7%), leaving about 720 of 1,565 registered patients unreviewed. Practice review rates span from 45.6% at Pelham Medical Practice to 69.9% at Rochester Road Surgery. Conversely, COPD reviews rose 10.8% over 2023 to 2025 (England +2.8%) to 70.0% (England 76.4%, register 500). Second-hand smoke status was recorded for 69.8% of asthma patients aged 6-19 (England 78.8%).

    Cancer register and children's immunisation

    Cancer register prevalence is 2.5% (875 patients), below England (3.8%). In Q1 2025/26, childhood immunisation trailed the 95.0% target: 6-in-1 at 24 months was 88.8%, MMR dose 1 at 24 months was 82.2%, age-5 MMR dose 2 was 81.6% (below target by 13.4 pp), and pre-school 4-in-1 booster coverage was 78.9% (below target by 16.1 pp).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months87.3%

    England 91.0%

    6-in-1 complete primary course at 24 months88.8%

    England 92.2%

    MMR dose 1 at 24 months82.2%

    England 88.3%

    MMR dose 2 at age 581.6%

    England 82.8%

    4-in-1 pre-school booster at age 578.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In 2022, NHS Kent and Medway ICB diagnosed 55.6% of staged cancers at stage 1 or 2 (England 55.3%), below the 75.0% national ambition by 2028; staging was known for 63.6% of registered cancers, requiring 1,627 extra early-stage cases a year to reach 75%. System-level staging does not measure PCN performance, but local preventive uptake is low: cervical screening coverage is 58.2% (England 66.8%), with Rochester Road Surgery at 53.6%, and breast screening is 57.2% (England 69.9%). Lower screening reach could reflect unverified engagement barriers that a recall audit would test, potentially delaying early identification.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional Jul 2026 data, Dartford and Gravesham NHS Trust met the 62-day cancer referral to treatment standard for 63.6% of pathways (85.0% standard), below Medway NHS Foundation Trust (81.6%), NHS Kent and Medway Integrated Care Board (75.9%), and England (71.2%). However, it met the 28-day faster diagnosis standard at 78.1% (standard 75.0%) and the 31-day combined treatment standard at 97.5% (standard 96.0%). For all diagnostic tests, 8.4% of patients waited 6+ weeks (England 23.1%). Prolonged 62-day waits at the local acute provider could delay treatment initiation.

    Pathways within standard (%)Dartford and GraveshamMedwayKent and Medway ICBEngland
    28-day faster diagnosis (75%)78.1477.7776.7879.32
    31-day treatment (96%)97.4899.6295.8492.50
    62-day referral to treatment (85%)63.5981.6475.9371.16
    Diagnostic waits over 6 weeks (%)Dartford and GraveshamKent HealthMedwayEngland
    MRI0.36—0.6821.40
    CT2.08—0.009.92
    Echocardiography3.90—36.6228.48
    Colonoscopy0.40—1.8830.83
    Gastroscopy0.00—3.3229.02
    All 15 DM01 tests8.3727.4914.2023.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In provisional Jun 2026 data, Kent residents received 210,170 community care contacts across 265,905 care activities covering 60,605 patients, with 65.8% of contacts involving adults aged 65+. Regionally, NHS Kent and Medway Integrated Care Board recorded 254,055 contacts. These experimental provider counts describe wider-system activity and are not PCN-specific.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Good practice experience spans 19.9 pp while vaccination achievement varies by 41.7 pp

    In 2025/26, QOF overall achievement ranged from 71.5% at Rochester Road Surgery to 94.5% at Pelham Medical Practice (England 92.5%). Across practices, vaccination achievement spanned 41.7 pp: Gravesend Medical Centre achieved 15.6% against an England level of 55.2%, while Pelham Medical Practice reached 57.3%.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Rochester Road6924.061.9%73.0%81.8%
    Gravesend8738.355.6%75.6%66.0%
    Pelham Medical12627.645.9%74.9%61.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNGraveshamAssetPCNGravesham
    Care homes (catchment)15 (591 beds)n/aSchools (catchment)69n/a
    Children's centres55Places of worship3146
    Libraries58Food banks (VCS)11
    Day centres (VCS)913Children and young people (VCS)n/a1
    Carers support groups (VCS)n/a2Primary schools (LA maintained)1216
    Primary academies1316Special schools34

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma annual review coverage is 53.9% (Gravesham 58.5%, NHS Kent and Medway ICB 60.4%, England 65.7%), leaving an estimated 722 (about 720) of 1,565 registered patients unreviewed. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Working-age hypertension control and recall

    On the 5,022 hypertension register, blood pressure control under age 80 is 59.2% (Gravesham 62.9%, NHS Kent and Medway ICB 64.6%, England 67.8%), below England by 8.7 pp; patient count is not sized. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Combined SMI physical health checks

    On the 346-patient SMI register, annual BP checks are 75.9% (Gravesham 77.7%, NHS Kent and Medway ICB 79.7%, England 83.4%), below England by 7.5 pp; patient count is not sized. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Demographic outreach and list reconciliation (p2)Registered populationNeighbourhood health frameworkPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Working-age hypertension recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation recall audit (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Working-age hypertension control and recall (p12)Hypertension register · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) · Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 3 · Combined SMI physical health checks (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15